טוען...
Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested CCP-Positive Patients Without RA
OBJECTIVE: We investigated risk of progression to rheumatoid arthritis (RA) in patients who were cyclic citrullinated antibody positive (CCP+) without RA at initial presentation. METHODS: We performed a retrospective cohort study of CCP+ individuals seen at a US tertiary care system between 2009-201...
שמור ב:
| הוצא לאור ב: | Arthritis Care Res (Hoboken) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6586539/ https://ncbi.nlm.nih.gov/pubmed/30570827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.23820 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|